The administration of intermittent parathyroid hormone affects functional recovery from pertrochanteric fractured neck of femur: A protocol for a prospective mixed method pilot study with randomisation of treatment allocation and blinded assessment (FRACTT)

BMJ Open

Volumn 4, Issue 1, 2014, Pages

  Chesser, Tim ^a   Fox, Rebecca ^a   Harding, Karen ^a   Greenwood, Rosemary ^b   Javaid, Kassim ^c   Barnfield, Steven ^a   Halliday, Ruth ^a   Willett, Keith ^d   Lamb, Sallie ^d  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY CONSERVATION AGENT; PARATHYROID HORMONE;

AGED; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECTS; FEMALE; FEMORAL NECK FRACTURES; FRACTURE HEALING; HUMAN; MALE; OUTCOME ASSESSMENT; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; BONE DENSITY CONSERVATION AGENTS; FEMALE; FEMORAL NECK FRACTURES; FRACTURE HEALING; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PARATHYROID HORMONE; PILOT PROJECTS; RECOVERY OF FUNCTION;

EID: 84894217775     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004389     Document Type: Article

References (23)

1. Melton L III. Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res 2003;18:1139-41. (Pubitemid 37294956)
2. Cree M, Carriere K, Soskolne C, et al. Functional dependence after hip fracture. Am J Phys Med Rehab 2001;80:736-43. (Pubitemid 32888738)
3. Magaziner J, Fredman L, Hawkes W, et al. Changes in functional status attributable to hip fracture: a comparison of hip fracture patients to community-dwelling aged. Am J Epidemiol 2003;157:1023-31. (Pubitemid 36628806)
4. Ellegaard M, Jørgensen NR, Schwarz P. Parathyroid hormone and bone healing. Calcif Tissue Int 2010;87:1-13.
5. Einhorn TA. Systemic administration of PTH 1-84 for fracture repair: an exciting prospect. J Bone Joint Surg Am 2011;93:1-2.
6. Barnes G, Einhorn T. Enhancement of fracture healing with parathyroid hormone. Clin Rev Bone Miner Metab 2006;4:269-75. (Pubitemid 46568225)
7. Barnes G, Kakar S, Vora S, et al. Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. J Bone Joint Surg Am 2008;90A:120-7. (Pubitemid 351329130)
8. Chalidis B, Tzioupis C, Tsiridis E, et al. Enhancement of fracture healing with parathyroid hormone: preclinical studies and potential clinical applications. Expert Opin Investig Drugs 2007;16: 441-9. (Pubitemid 46554463)
9. Jahng JS, Kim HW. Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectamized rats. Orthopedics 2000;23:1089-94.
10. Andreasson T, Fledelius C, Ejersted C, et al. Increases in callus formation and mechanical strength of healing fractures in old rats with parathyroid hormone. Acta Orthop Scand 2001; 72:304-7. (Pubitemid 32613496)
11. Holzer G, Majeska R, Lundy M, et al. Parathyroid hormone enhances fracture healing: a preliminary report. Clin Orthop Relat Res 1999;366:258-63. (Pubitemid 29439363)
12. Skripitz R, Aspenberg P. Implant fixation enhanced by intermittent treatment with parathyroid hormone. J Bone Joint Surg Br 2001;83B:437.
13. Alkihiary Y, Gerstenfield L, Krall E, et al. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am 2005;87:731.
14. Morley P. Delivery of parathyroid hormone for the treatment of osteoporosis. Expert Opin Drug Deliv 2005;2:993-1002. (Pubitemid 41701199)
15. Crosman F, Lane N, Bolognese M, et al. Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women. J Clin Endocrinol Metab 2010;95: 151-8.
16. Charmaz K. Constructing grounded theory: a practical guide through qualitative analysis. London: Sage, 2006.
17. Piechel P, Holzer LA, Maier R, et al. Parathyroid hormone 1-84 accelerates fracture healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am 2011;93:1583-7.
18. Aspenberg P, Genant H, Johansson T, et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomised, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 2010;25:404-14.
19. National Institute for Health and Clinical Evidence. Venous thromboembolism; reducing the risk: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. 2010. http://www.nice.org.uk/ nicemedia/live/12695/47195/47195.pdf (accessed Mar 2010).
20. Dawson-Hughes B, Chen P, Krege J. Response to teriparatide in patients with baseline 25-hydroxyvitamin D insufficiency or sufficiency. J Clin Endocrinol Metab 2007;92:4630-6. (Pubitemid 350223437)
21. National Institute for Clinical Excellence (NICE). Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (amended). 2010. http://www.nice.org.uk/ nicemedia/live/11748/47177/47177. pdf (accessed Mar 2010).
22. Guralnik J, Simonsik E, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85-94. (Pubitemid 24100267)
23. Grbich C. Qualitative research in health; an introduction. London: Sage, 1999.